Genmab — Marts 2014
-
sidder david lige og kommenterer cliniske data?
-
ahh - tak solsen. 2015 lyder også lidt sent
-
svarer det ikke til at få stig tøfting til at undervise i Laudrup tricks?
-
og jo - guadance er meget konservativ
-
ham Sachin lyder så sjov
-
dlbcl - hvad er forventninger - Kempen
-
ASCO - hvad bliver præsenteret på dara
-
dlbcl - relapsed mostly, en del refractory
-
hovedsageligt behandlet med rituxan+chop
-
continue to be optimistic there is a difference btw arms
-
dvs arzerra lammetæsker guldstandarden i direkte kamp med rituxan!!!!!!!!!!!!!!!!
-
masser abstracts til ASCO. Sådan
-
for asco - multiple abstracts submitted
-
både mono og revlimid
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind